| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Stephan von Haehling | Q50639680 |
| P2093 | author name string | Nicole Ebner | |
| P2860 | cites work | Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data | Q21261840 |
| Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease | Q24634143 | ||
| Safety and efficacy of iron(III)-hydroxide polymaltose complex / a review of over 25 years experience | Q28240231 | ||
| Hepcidin in human iron disorders: diagnostic implications | Q28250198 | ||
| Iron and porphyrin trafficking in heme biogenesis | Q33349194 | ||
| Structure, function and clinical significance of transferrin receptors | Q33545639 | ||
| Role of iron in optimizing responses of anemic cancer patients to erythropoietin. | Q33611413 | ||
| Iron-Overload Cardiomyopathy: Pathophysiology, Diagnosis, and Treatment | Q33740236 | ||
| Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol | Q33934515 | ||
| Treatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease | Q34064046 | ||
| The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate | Q34113833 | ||
| Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes | Q57484579 | ||
| Myocardial iron homeostasis in advanced chronic heart failure patients | Q60584915 | ||
| Immunological measurement of transferrin compared with chemical measurement of total iron-binding capacity | Q66940815 | ||
| Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization | Q68255477 | ||
| Interactions of iron deficiency and exercise training relative to tissue norepinephrine turnover, triiodothyronine production and metabolic rate in rats | Q68876059 | ||
| [Intravenous iron-dextran: therapeutic and experimental possibilities] | Q71417912 | ||
| Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency | Q73062570 | ||
| Structure, chemistry, and pharmacokinetics of intravenous iron agents | Q81110731 | ||
| Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival | Q84917372 | ||
| Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial | Q34182887 | ||
| Parenteral iron therapy options | Q35758858 | ||
| Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney | Q35810338 | ||
| Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives | Q36682182 | ||
| Assessing iron status: beyond serum ferritin and transferrin saturation | Q36910512 | ||
| Iron status in patients with chronic heart failure | Q36971596 | ||
| Iron and anemia in human biology: a review of mechanisms | Q37117678 | ||
| Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status | Q37195233 | ||
| Anemia and mortality in heart failure patients a systematic review and meta-analysis | Q37255449 | ||
| Mammalian iron transport. | Q37502811 | ||
| Intravenous iron in heart failure: beyond targeting anemia | Q37807903 | ||
| Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches | Q37883005 | ||
| Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: a meta-analysis | Q38048880 | ||
| The effects of iron deficiency on the respiratory function and cytochrome content of rat heart mitochondria | Q40019368 | ||
| Iron deficiency: improved exercise performance within 15 hours of iron treatment in rats | Q41205049 | ||
| Ferric carboxymaltose in patients with heart failure and iron deficiency | Q43240282 | ||
| Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure. | Q44429130 | ||
| L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy | Q44560867 | ||
| Iron deficiency in chronic heart failure: an international pooled analysis | Q46257022 | ||
| Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. | Q46645329 | ||
| Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial | Q46810797 | ||
| Iron deficiency: an ominous sign in patients with systolic chronic heart failure | Q48155909 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P921 | main subject | heart failure | Q181754 |
| iron deficiency anemia | Q954674 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 3730-3739 | |
| P577 | publication date | 2013-09-23 | |
| P1433 | published in | Nutrients | Q7070485 |
| P1476 | title | Iron deficiency in heart failure: a practical guide | |
| P478 | volume | 5 |
| Q52861755 | Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). |
| Q91720588 | Efficacy and safety of iron supplementation in patients with heart failure and iron deficiency: a meta-analysis |
| Q38757052 | Hemoglobin Concentration Influences N-Terminal Pro B-Type Natriuretic Peptide Levels in Hospitalized Older Adults with and without Heart Failure. |
| Q38551016 | Iron deficiency and cardiovascular disease |
| Q26822876 | Iron deficiency in patients with heart failure |
| Q64091017 | Iron induces insulin resistance in cardiomyocytes via regulation of oxidative stress |
| Q48017007 | Iron restriction increases myoglobin gene and protein expression in Soleus muscle of rats |
| Q27012538 | Is Correction of Iron Deficiency a New Addition to the Treatment of the Heart Failure? |
| Q41491760 | Lipopolysaccharide responsiveness is an independent predictor of death in patients with chronic heart failure |
| Q33720452 | Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: The PrEP Registry |
| Q91587899 | The Influence of Cardiovascular Medications on Iron Metabolism in Patients with Heart Failure |
| Q39409288 | Towards Holistic Heart Failure Management-How to Tackle the Iron Deficiency Epidemic? |
Search more.